Stockreport

Rain Therapeutics to Present on Milademetan at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

Rain Oncology Inc.  (RAIN) 
PDF NEWARK, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NEWARK, Calif., October 1, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., (NasdaqGS: RAIN), (“Rain”), a late-stage [Read more]